In the TARGET dataset, favourable tumour histology (Figure 2E) and NTRK1-PTPN6-TP53 module activation (Figure 2F) were significantly associated with a lower prognostic score (p < 0.0001). This evidence concerns the gene PTPN6 and neoplasm.